Who
Lee Troy Schalop
Director
Company insider
Files Form 4 as: Director, Lantern Pharma.
In numbers
- Trades disclosed
- 9
- Buys
- 1
- Sells
- 0
- Bought
- $200K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 19 Aug 2025
- Last trade
- 12 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 14 May 2026 | LTRN Lantern PharmaBiotechnology | SEC FORM 4 Bought | $100K48,544 at $2.06 | filing |
| 12 May 2026filed 14 May 2026 | LTRN Lantern Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code P | —48,544 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | LTRN Lantern Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code P | —48,544 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | LTRN Lantern PharmaBiotechnology | SEC FORM 4 Bought | $100K48,544 at $2.06 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LTRN Lantern Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LTRN Lantern Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,460 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LTRN Lantern Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | LTRN Lantern Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,460 at $0.00 | filing |
| 19 Aug 2025filed 20 Aug 2025 | LTRN Lantern Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
News
Lantern Pharma (NASDAQ:LTRN) Stock Price Up 1.4% – Here's What HappenedLTRN · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Lee Troy Schalop; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.